Medicare Enrolled
Dr. Martin Grajower, MD
Endocrinology · Bronx, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Grajower from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grajower?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Grajower
Dr. Martin Grajower is an endocrinology specialist in Bronx, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Grajower performed 21,230 Medicare services across 3,991 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grajower received a total of $706,172 from 51 pharmaceutical and/or device companies across 1311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grajower is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in NY
$706,172 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,230
Medicare services
Top 4% in NY for endocrinology
3,991
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,117 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 13,560 | $18 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,156 | $8 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,153 | $109 | $350 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
707 | $56 | $150 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
515 | $4 | $10 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
458 | $43 | $150 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
450 | $3 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
337 | $79 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
280 | $13 | $50 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
279 | $13 | $90 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
267 | $49 | $200 |
| Ultrasound scan of organ tissue for measuring elasticity This procedure uses ultrasound technology to assess the stiffness or elasticity of organ tissues. It helps evaluate tissue characteristics without invasive methods. |
190 | $98 | $224 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
180 | $61 | $324 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
172 | $36 | $50 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
170 | $6 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
160 | $72 | $75 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
156 | $116 | $325 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
154 | $76 | $250 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
154 | $82 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
139 | $152 | $362 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
120 | $178 | $500 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
98 | $31 | $85 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
47 | $58 | $150 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
43 | $30 | $75 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
40 | $46 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $145 | $500 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
34 | $57 | $200 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
33 | $55 | $250 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
30 | $47 | $100 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $22 | $90 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
22 | $41 | $50 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
21 | $80 | $150 |
| New patient office visit, complex (60-74 min) | 16 | $193 | $575 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $94 | $275 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $256 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
68.2% medium
31.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$706,172
Total received (2018-2024)
Avg $100,882/year across 7 years
Top 1% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,311
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$651,892 (92.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$45,427 (6.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,852 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$129,632
2023
$107,517
2022
$117,021
2021
$101,529
2020
$69,616
2019
$85,592
2018
$95,265
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$80,330
Novo Nordisk Inc
$34,670
Echosens North America, Inc.
$13,572
Amneal Pharmaceuticals LLC
$134
Bayer Healthcare Pharmaceuticals Inc.
$95
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
Esperion Therapeutics, Inc.
$90
Abbott Laboratories
$73
SANOFI-AVENTIS U.S. LLC
$73
RECORDATI_RARE_DISEASES_INC.
$69
Amgen Inc.
$66
Novartis Pharmaceuticals Corporation
$65
Xeris Pharmaceuticals, Inc.
$46
Radius Health, Inc.
$45
GlaxoSmithKline, LLC.
$45
ABBVIE INC.
$36
Tandem Diabetes Care, Inc.
$35
Neurocrine Biosciences, Inc.
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Madrigal Pharmaceuticals
$22
Corcept Therapeutics
$19
Top 3 companies account for 99.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$423,744
Lilly USA, LLC
$144,909
Bayer HealthCare Pharmaceuticals Inc.
$57,918
Echosens North America, Inc.
$45,427
Abbott Laboratories
$17,166
Bayer Healthcare Pharmaceuticals Inc.
$6,277
Quidel Corporation
$2,500
Amgen Inc.
$991
AstraZeneca Pharmaceuticals LP
$945
Boehringer Ingelheim Pharmaceuticals, Inc.
$905
Astellas Pharma US Inc
$682
Amneal Pharmaceuticals LLC
$681
SANOFI-AVENTIS U.S. LLC
$434
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$355
AbbVie Inc.
$288
AbbVie, Inc.
$277
Radius Health, Inc.
$231
Novartis Pharmaceuticals Corporation
$212
ABBVIE INC.
$208
Corcept Therapeutics
$185
Janssen Pharmaceuticals, Inc
$180
GlaxoSmithKline, LLC.
$155
Amarin Pharma Inc.
$125
IBSA Pharma Inc.
$124
Esperion Therapeutics, Inc.
$122
MannKind Corporation
$100
Shire North American Group Inc
$97
Merck Sharp & Dohme Corporation
$92
RECORDATI_RARE_DISEASES_INC.
$88
IDORSIA PHARMACEUTICALS US INC
$67
IRONWOOD PHARMACEUTICALS, INC
$67
Tandem Diabetes Care, Inc.
$62
Currax Pharmaceuticals LLC
$53
DEXCOM, INC.
$51
Xeris Pharmaceuticals, Inc.
$46
Allergan Inc.
$46
Nevro Corp.
$43
Insulet Corporation
$42
Ironwood Pharmaceuticals, Inc
$41
Neurocrine Biosciences, Inc.
$27
Eisai Inc.
$24
Horizon Therapeutics plc
$23
Madrigal Pharmaceuticals
$22
Amryt Pharma Holdings Ltd
$20
Orexigen Therapeutics, Inc.
$19
Ultragenyx Pharmaceutical Inc.
$19
Seqirus USA Inc
$18
Medtronic, Inc.
$17
VIVUS, Inc.
$17
ARKRAY USA, Inc.
$17
CeQur Corporation
$16
Top 3 companies account for 88.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APRISO · BAQSIMI · BEVESPI AEROSPHERE · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · DEXCOM G6 TRANSMITTER · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FibroScan · Fluad · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · HUMALOG · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LINZESS · Levemir · Linzess · MOUNJARO · MYCAPSSA · MYRBETRIQ · Myrbetriq · NATPARA · NEXLETOL · Omnia · Omnipod · Ozempic · PRADAXA · Prolia · QSYMIA · QUVIVIQ · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRELEGY ELLIPTA · TRULANCE · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in NY.
Geographic Context
Endocrinologists within 10 mi
687
Per 100K population
48.4
County median income
$49,036
Nearest hospital
BRONX VA MEDICAL CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Grajower is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Grajower experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Grajower performed 13,560 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grajower receive payments from pharmaceutical companies?
Yes. Dr. Grajower received a total of $706,172 from 51 companies across 1,311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grajower's costs compare to other endocrinologists in Bronx?
Dr. Grajower's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grajower) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Bronx
Browse endocrinologists in Bronx ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology